Notice Title

Consent to the Distribution of a New Medicine

Publication Date
31 May 2023

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2023-go2299
Title
View PDF
File Type and Size
PDF (33 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Remsima
Active Ingredient: Infliximab 100mg
Dosage Form: Powder for injection
New Zealand Sponsor: Celltrion Healthcare New Zealand Limited
Manufacturers: Celltrion Inc., Incheon, South Korea
Gensenta llac Sanayii ve Ticaret A.S., Instanbul, Turkey


Dated this 30th day of May 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).